SEC Form 4 · accession 0001209191-15-032714
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert C Young
Director
Period of report
Apr 2, 2015
Accepted (ET)
Apr 6, 2015 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F2 | $1.61 | Apr 2, 2015 | A | 25,155 | A | — | Apr 2, 2025 | Common Stock | 25,155 | 25,155 | D |
Explanation of responses
- F1The transaction reported in this Form 4 was effected pursuant to a board policy adopted in April 2015, to receive 100% of the reporting person's retainer payment for board member service in the form of stock options, issued under the issuer's amended and restated 2010 Stock Incentive Plan, as amended.
- F2This option vests in four equal quarterly installments commencing on January 1, 2015 and ending on December 31, 2015.